Amgen reported strong revenue and earnings growth, raised full-year guidance, and demonstrated robust pipeline advancements, which signal positive momentum. Managementâ€™s optimistic tone and ongoing share repurchase program further support investor confidence. These factors are likely to drive the stock higher in the short term.

[2]